CHICAGO -- The neurokinin-targeted agent elinzanetant significantly reduced the frequency of hot flashes among women ...

Veozah (fezolinetant) was approved in 2023 by the FDA to treat moderate to severe hot flashes. A similar drug, elinzanetant, ...

Hydrocortisone oral solution (Khindivi) was approved as a replacement therapy for pediatric patients ages 5 years and up with ...

Elinzanetant proved effective for managing disruptive vasomotor symptoms in women on endocrine therapy, supporting a Bayer ...

Hot flashes happened less often and were less severe in women who took elinzanetant compared to those who took a placebo. The ...

Hot flashes are sudden surges of sweat, sudden heat, or flushed skin. They are a common symptom of menopause. According to J ...

When the FDA approved fezolinetant for treating moderate to severe hot flashes in menopausal women, the news made headlines.

According to a McKinsey analysis, women spend 25% more time than men in poor health — and investments addressing the women’s ...

For many generations, menopause was a taboo topic. Despite 6,000 women reaching menopause in the U.S. each day, this pivotal ...

Speaking to PEOPLE exclusively while at the BCRF Hot Pink Party, ‘Bachelorette’ star Katie Thurston gave an update on how she ...

For women at higher risk of breast cancer, there is a proven way to cut the risk in half: take an anti-cancer drug such as ...